Abstract
In connection with the upcoming transition to the International Classification of Diseases and Health-related Problems of the eleventh revision (ICD-11), the authors of the article propose to replace the term toxidermy with a new, widely used in the world term drug-induced skin reactions. The article presents a list of various variants of drug-induced rashes, which are included in the draft ICD-11. For standardization of definitions and diagnostic criteria, a unified working classification of this group of diseases is based on a mixed principle clinical manifestations (primary morphological elements of skin rash), etiological and pathogenetic aspects are taken into account. The applied unified classification of drug-induced skin reactions is proposed for discussion. Examples of the formulation of clinical diagnoses are given. Severe drug-induced skin reactions are described, which are potentially life-threatening for the patient, can lead to disability and require mandatory hospitalization.
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
Subject
Infectious Diseases,Dermatology
Reference21 articles.
1. Токсидермия. Клинические рекомендации. 2020. Доступно: https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020. [Toksidermiya. Klinicheskie rekomendacii (Toxidermia. Сlinical practice guidelines). 2020. Available from: https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020 (In Russ.)].
2. Toxidermias. Hospital (Lond 1886). 1919;66(1722):239–240.
3. Zoon JJ. Toxidermia. Ned Tijdschr Geneeskd. 1952;96(35):2175–2176.
4. Revuz J. Should we stop using the term "toxidermia" in pathology reports? Ann Dermatol Venereol. 1999;126(4):376–379.
5. Drug-induced cutaneous pathology